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Abstract
Peroxynitrite, formed by the reaction between nitric oxide and superoxide, leads to the oxidation of proteins, lipids, and
DNA, and nitrates thiols such as cysteine and glutathione, and amino acids like tyrosine. Previous in vitro studies have
shown glutathione to be an efficient scavenger of peroxynitrite, protecting synaptosomal membranes from protein oxidation,
the enzyme glutamine synthetase from inactivation, and preventing the death of hippocampal neurons in culture. The current
study was undertaken to see if in vivo modulation of glutathione levels would affect brain cortical synaptosomal membrane
proteins and their subsequent reaction with peroxynitrite. Glutathione levels were depleted, in vivo, by injecting animals with
2-cyclohexen-1-one (CHX, 100 mg/kg body weight), and levels of glutathione were enhanced by injecting animals with N-
acetylcysteine (NAC, 200 mg/kg body weight), which gets metabolized to cysteine, a precursor of glutathione. Changes in
membrane protein conformation and structure in synaptosomes subsequently isolated from these animals were examined
using electron paramagnetic resonance, before and after in vitro addition of peroxynitrite. The animals injected with the
glutathione depletant CHX showed greater damage to the membrane proteins both before and after peroxynitrite treatment,
compared to the non-injected controls. The membrane proteins from animals injected with NAC were comparable to
controls before peroxynitrite treatment and were partially protected against peroxynitrite-induced damage. This study
showed that modulation of endogenous glutathione levels can affect the degree of peroxynitrite-induced brain membrane
damage and may have potential therapeutic significance for oxidative stress-associated neurodegenerative disorders. ß 1999
Elsevier Science B.V. All rights reserved.
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Peroxynitrite (ONOO3) is the cytotoxic product of
the reaction between nitric oxide and superoxide
anion, and this anion is known to lead to the oxida-
tion of several cellular components, including pro-
teins, lipids, and DNA, and result in the nitration
of many amino acids, mainly tyrosine [1]. Peroxyni-
trite is also known to inactivate key mitochondrial
enzymes and a¡ect the cellular energy status resulting
in apoptosis (for a review, see [1]). The protonated
form of peroxynitrite, peroxynitrous acid (ONOOH),
is known to be a highly reactive oxidant species (re-
viewed in [2]). But whether it is the active intermedi-
ate of ONOOH (ONOOH*) with a hydroxyl radical-
like reactivity or the hydroxyl radical itself that is
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formed by the decomposition of ONOOH that is
responsible for the deleterious e¡ects of peroxynitrite
is still questionable.
Consistent with the notion of peroxynitrite-in-
duced oxidative stress, previous studies showed that
peroxynitrite caused conformational and structural
changes in brain cortical synaptosomal membrane
proteins and led to increased protein carbonyl levels
[3]. Peroxynitrite also led to inactivation of the highly
oxidation-sensitive enzyme glutamine synthetase
(GS), and caused cell death in hippocampal neuronal
cultures [3]. In all these in vitro experiments when the
cellular antioxidant glutathione (GSH) was added to
the system prior to the addition of peroxynitrite, sig-
ni¢cant protection was observed against the peroxy-
nitrite-induced damage [3]. Glutathione is a tripep-
tide (Glu-Cys-Gly) and a known scavenger of
peroxynitrite [2]. Peroxynitrite was shown to nitrate
glutathione and such S-nitrosothiol species have been
found in ALS patients [4] and in rat cerebellar ex-
tracts [5].
The goal of the current study was to assess the
susceptibility of synaptosomal membrane proteins
to peroxynitrite-mediated oxidative stress by modu-
lating the endogenous levels of glutathione in vivo
and studying the protein damage to subsequently
isolated cortical synaptosomes. Intracellular levels
of glutathione were reduced employing i.p. injections
of 2-cyclohexen-1-one (CHX), while the levels of in-
tracellular glutathione were increased using N-acetyl-
cysteine (NAC).
Peroxynitrite was synthesized using sodium azide
and ozone as described earlier [6]. Before each ex-
periment the solution containing peroxynitrite was
thawed on ice and the absorbance measured at
302 nm to determine the concentration of peroxyni-
trite present. Male Mongolian gerbils, 3^5 months of
age, were used. The animals were injected i.p. with
100 mg/kg body weight CHX for the glutathione
depletion studies, and 200 mg/kg body weight NAC
for glutathione enhancement studies. These doses
were based on previous studies [7^9]. The animals
given CHX were killed 1 h later, and those given
NAC were killed 3 h after injection, by decapitation,
and the brains quickly dissected on ice. The times
chosen for the study were based on time response
studies conducted (data not shown),
The isolation of synaptosomes by ultracentrifuga-
tion of the homogenized cortices was performed as
described earlier [10]. Puri¢ed synaptosomes ob-
tained at the 1.18 M/1.10 M sucrose gradient inter-
face were washed three times with V30 ml lysing
bu¡er (10 mM HEPES, 2 mM EDTA and 2 mM
EGTA in deionized water, pH 7.4) containing
100 WM diethylenenetriaminepentaacetic acid
(DTPA), a chelator for iron. After the three washes
the synaptosome membranes were resuspended in
V1 ml lysing bu¡er and the protein concentration
of each homogenate was adjusted to 4 mg/ml. The
protein aliquots were centrifuged at 14 000 rpm for
4 min. The protein pellets obtained were then treated
with 250 WM peroxynitrite, in lysing bu¡er, for
10 min and the washed homogenates were spin-
labeled with the protein-speci¢c spin label 2,2,6,6-
tetramethyl-4-maleimidopiperidine-1-oxyl (MAL-6)
and the electron paramagnetic resonance (EPR) spec-
tra obtained by methods described previously [3,10].
The data were analyzed for statistical signi¢cance
using Dunnett’s test for one-way ANOVA followed
by Student’s t-test. A value of PG0.05 was considered
to be statistically signi¢cant for comparison between
data sets.
Proteins are generally non-paramagnetic species
and hence the thiol-speci¢c spin label MAL-6 is
Fig. 1. Schematic of the low ¢eld region of the EPR spectrum
showing the W and S components of the MAL-6-labeled synap-
tosomal membrane proteins.
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used to study the protein micro-environment by
EPR. MAL-6 covalently labels sulfhydryl groups
on proteins located on the protein surface or in
deep pockets. The former group of -SH sites leads
to spin label motion that is weakly immobilized,
while reaction of MAL-6 with the latter group of
-SH sites leads to spin label motion that is strongly
hindered [11]. Accordingly, the EPR spectrum of
MAL-6-labeled proteins in synaptosomal membranes
has a weakly (W) and strongly (S) immobilized com-
ponent (Fig. 1). The ratio of the signal amplitudes of
these two components of the MI = +1 low ¢eld region
of the EPR spectrum, the W/S ratio, is extremely
sensitive to alterations in the protein environment
[11]. A decrease in the W/S ration results from in-
creased protein-protein interactions, increased pro-
tein cross-linking, and changes in protein conforma-
tion [11]. Previous models of oxidative stress studied
in our laboratory, such as hydroxyl radical genera-
tion [10], hyperoxia [12], ischemia/reperfusion [7], ac-
celerated aging [13], and amyloid-L-induced damage
[14,15], have all shown decreased W/S ratios of spin-
labeled synaptosomes with increasing oxidative
stress.
Con¢rming the results of our previous study [3]
and consistent with oxidative stress, synaptosomal
membranes isolated from control animals and
treated with 250 WM peroxynitrite for 10 min showed
V50% decrease in W/S ratios compared to the un-
treated control membranes (P6 0.001, Fig. 2). The
membranes isolated from the CHX-injected animals
showed W/S ratios lowered to about 85% compared
to those isolated from control animals (P6 0.01, Fig.
2), con¢rming data previously obtained [7]. In con-
trast, there was essentially no di¡erence between the
W/S ratios of the NAC-injected animals (102%) and
control animals, P6 0.2 (Fig. 3).
Synaptosomal membranes isolated from the CHX-
injected animals, when treated with 250 WM peroxy-
nitrite for 10 min, showed W/S ratios lowered to 39%
compared to the untreated control samples
(P6 0.001, Fig. 2). This mean decrease in W/S ratio
was statistically signi¢cant and V11% lower than
the mean decrease observed when the control sam-
ples were treated with peroxynitrite alone (P6 0.02),
suggesting that the membrane proteins isolated from
Fig. 3. Synaptosomal membranes were isolated from control
animals and NAC-treated (200 mg/kg body weight) animals.
Synaptosomal membranes were isolated from the animals 3 h
after injection. W/S ratios of membrane proteins isolated from
controls and NAC-injected animals were not statistically di¡er-
ent (Ps 0.2). 250 WM peroxynitrite added in vitro to mem-
branes isolated from NAC-treated animals for 10 min showed a
signi¢cant decrease in W/S ratios from untreated control values
(*P6 0.001) but was signi¢cantly higher than the values ob-
tained with peroxynitrite-treated control membranes (P6 0.01).
N = 7 was used for each group in the study.
Fig. 2. Synaptosomal membranes were isolated from control
animals and animals injected i.p. with CHX (100 mg/kg body
weight) animals. The CHX-treated animals were decapitated 1 h
after injection and synaptosomal membranes were isolated from
brain cortices. W/S ratios of membrane proteins isolated from
CHX-injected animals were statistically di¡erent from the W/S
ratios of control animals (*P6 0.01). 250 WM peroxynitrite
added in vitro to membranes isolated from control animals
showed lower W/S ratios, compared to the untreated mem-
branes (**P6 0.001). Membranes isolated from CHX-treated
animals and treated with peroxynitrite for 10 min showed an
even greater decrease in W/S ratios compared to both control
untreated membrane proteins (***P6 0.001) and control pro-
teins treated with peroxynitrite (P6 0.02). N = 6 was used for
each group under study.
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CHX-injected animals were more vulnerable to dam-
age mediated by peroxynitrite. In contrast, the de-
crease observed in W/S ratios of membrane proteins
isolated from NAC-injected animals and treated with
peroxynitrite was about 61% (P6 0.001), which is
V11% higher than the W/S ratios of membranes
from control animals treated with peroxynitrite
(P6 0.01, Fig. 3), implying a lesser extent of protein
damage. Thus, increased glutathione levels from
NAC injections o¡ered partial protection against
peroxynitrite-induced oxidative stress.
This study showed that injecting the animals with
CHX caused a decrease in W/S ratios of MAL-6
covalently bound to cortical synaptosomal mem-
brane proteins isolated from such animals. A pre-
vious study also showed signi¢cant changes in the
physical state of membrane proteins after administra-
tion of CHX alone and CHX followed by ischemia/
reperfusion in gerbils [7]. This result thus suggested
that diminution of glutathione levels alone leads to
increased oxidative stress. In contrast, animals in-
jected with NAC showed no change in W/S ratios
of membrane proteins compared to control animals,
which implied no change in protein interactions and
conformation or oxidative stress status.
CHX and NAC are well documented to be gluta-
thione-depleting and glutathione-enhancing agents,
respectively [7^9,16,17]. Studies have shown CHX
to be very e¡ective in lowering the amounts of re-
duced glutathione (GSH) because of its ability to
cross the blood-brain barrier and conjugate with glu-
tathione present in the brain [7,18,19]. On the other
hand, NAC acts as a glutathione agonist by metab-
olizing to form cysteine, a precursor for the biosyn-
thesis of glutathione. NAC is also known to scavenge
radicals like hydroxyl radicals, and superoxide and
react with reactive oxygen species such as H2O2 and
HOCl [20]. Glutathione is one of the most e¡ective
non-enzymatic, cytosolic antioxidants and is present
in high concentrations in the cell (millimolar range).
Glutathione mainly exists in the reduced form
(GSH), which is converted to its oxidized from
(GSSG) to maintain the reduced state of protein thi-
ols. Thus, the ratio of GSSG/GSH is an important
marker of oxidative stress. The role of GSH in oxi-
dative stress-mediated neuronal death in neurodege-
nerative diseases is discussed in detail in the review
by Bains et al. [21]. Glutathione scavenges oxygen
radicals like hydroxyl radicals and singlet oxygen,
and also acts as a substrate for the antioxidant en-
zyme glutathione peroxidase; the latter helps convert
hydrogen peroxide to water. Glutathione peroxidase
is also known to reduce peroxynitrite [22].
This study showed that in vivo depletion of gluta-
thione by systemic injection of CHX alone can lower
W/S ratios of membrane proteins. If glutathione lev-
els are low the thiol groups on membrane proteins
can be oxidized to form disul¢de bonds that are not
easily reduced back to the free sulfhydryl groups.
Disul¢de bonds can lead to increased protein cross-
linking, thereby decreasing protein segmental mo-
tion, increasing steric hinderance, and lowering the
W/S ratios of MAL-6-labeled membranes. In vitro
addition of peroxynitrite to the glutathione-depleted
membranes can further exacerbate these e¡ects, since
both the current investigation and our earlier study
[3] showed that 250 WM peroxynitrite by itself can
increase protein-protein interactions, following oxi-
dative stress. Also, with lowered glutathione levels
peroxynitrite cannot be scavenged e⁄ciently.
Administering NAC alone to the animals pro-
tected against autooxidation of the membrane pro-
teins, and treatment of synaptosomal membranes iso-
lated from NAC-treated animals with peroxynitrite
caused a signi¢cant increase in the W/S ratios com-
pared to the peroxynitrite-treated control animals.
However, the protection o¡ered was only partial.
These results showed that administering NAC intra-
peritoneally was not the most e¡ective route for de-
livering the drug. NAC delivered by some other
route could conceivably metabolize faster to cysteine,
the precursor for the synthesis of glutathione.
The current study reiterated that glutathione is an
extremely important cellular antioxidant that can
work against peroxynitrite-induced damage to mem-
brane proteins. Parkinson’s disease patients known
to have low glutathione and glutathione peroxidase
levels are already being put on glutathione therapy
[23,24]. There is increased evidence for oxidative
stress in Alzheimer’s disease brain [14,25], such as
protein oxidation, assessed by EPR and other means
[26^28]. Also, amyloid-L peptide is known to stimu-
late iNOS, which can lead to increased peroxynitrite
formation [29]. Hence, the current results are consis-
tent with the concept that increasing endogenous lev-
els of glutathione in Alzheimer’s disease patients con-
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ceivably could become a promising therapeutic strat-
egy.
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